10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionFranklin Resources Inc
Latest Disclosed Ownership286,398 shares
Latest Disclosed Value $ 6,080,230
Franklin Resources Inc reports 14.55% increase in ownership of TXG / 10x Genomics, Inc.

On May 13, 2026 - Franklin Resources Inc filed a 13F-HR form disclosing ownership of 286,398 shares of 10x Genomics, Inc. (MX:TXG) valued at $6,080,230 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 250,016 shares of 10x Genomics, Inc.. This represents a change in shares of 14.55% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 286,398 36,382 14.55 6,080 49.13 0.0002
2026-02-11 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 250,016 -99,786 -28.53 4,078 -0.29 0.0010
2025-11-13 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 349,802 -32,958 -8.61 4,089 -7.74 0.0010
2025-08-12 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 382,760 316,144 474.58 4,432 662.82 0.0012
2025-05-13 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 66,616 3,263 5.15 582 -36.08 0.0002
2025-02-12 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 63,353 68 0.11 910 -11.66 0.0003
2024-11-27 2024-09-30 13F/A-1 10X GENOMICS CL A COM 88025U109 63,285 -59,019 -48.26 1,030 -56.73 0.0003
2024-11-12 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 63,285 -59,019 1,030 0.0000
2024-08-14 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 122,304 -758,860 -86.12 2,379 -92.81 0.0007
2024-05-13 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 881,164 353,587 67.02 33,070 12.01 0.0105
2024-02-09 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 527,577 -97,803 -15.64 29,523 14.45 0.0138
2023-11-13 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 625,380 120,755 23.93 25,797 -8.45 0.0131
2023-08-11 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 504,625 411 0.08 28,178 0.17 0.0134
2023-05-12 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 504,214 11,676 2.37 28,130 56.73 0.0141
2023-02-10 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 492,538 -21,659 -4.21 17,948 22.55 0.0093
2022-11-14 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 514,197 -288,583 -35.95 14,645 -59.68 0.0080
2022-08-11 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 802,780 117,264 17.11 36,326 -30.34 0.0180
2022-05-13 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 685,516 -453,820 -39.83 52,148 -69.27 0.0208
2022-02-11 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 1,139,336 -108,945 -8.73 169,716 -6.61 0.0612
2021-11-12 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 1,248,281 3,485 0.28 181,725 -25.45 0.0684
2021-08-13 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 1,244,796 49,530 4.14 243,756 12.67 0.0931
2021-05-13 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 1,195,266 56,567 4.97 216,344 34.18 0.0880
2021-02-10 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 1,138,699 337,612 42.14 161,240 61.44 0.0682
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 801,087 335,338 72.00 99,879 126.66 0.0484
2020-08-13 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 465,749 244,903 110.89 44,065 220.17 0.0227
2020-05-13 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 220,846 133,149 151.83 13,763 105.82 0.0092
2020-03-11 2019-12-31 13F/A-1 10X GENOMICS CL A COM 88025U109 87,697 142 0.16 6,687 51.53 0.0035
2020-02-12 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 87,697 6,687
2019-11-14 2019-09-30 13F 10X GENOMICS CL A COM 88025U109 87,555 87,555 4,413 0.0024
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.